Immunotherapy Target Constructs

Lentiviral Particles expressing CAR-T-Cell Therapy Target Antigens
GenTarget´s lentiviral particles overexpressing immune checkpoint proteins have been developed to transduce primary cells for immunotherapy research. The sequence-verified ORFs are expressed under an optionally inducible suCMV promoter. The particles can be used for regular constitutive high expression (without any induction) or for inducible expression with tetracycline or Dox induction when the tetracycline repressor protein (TetR) is present.


Showing 1–20 of 22 results